UPC - Universe Pharmaceuticals INC

2.91
-0.710   -24.399%

Share volume: 57,632
Last Updated: 02-12-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.26%

PREVIOUS CLOSE
CHG
CHG%
$3.62
-0.71
-0.20%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0   0%
1 Month
-26.77%
3 Months
-34.61%
6 Months
-23.02%
1 Year
2,071.64%
2 Year
69.19%
Key data
Stock price
$2.91
P/E Ratio 
0.00
DAY RANGE
$2.91 - $3.76
EPS 
N/A
52 WEEK RANGE
$0.08 - $11.00
52 WEEK CHANGE
$2,104.55
MARKET CAP 
11.781 M
YIELD 
N/A
SHARES OUTSTANDING 
3.625 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
03-24-2025
NEXT EARNINGS DATE
04-29-2025
BETA 
0.30
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
$20,224
Company detail
CEO: Gang Lai
Region: US
Website: www.dzrzy.com/
Employees: 220
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Universe Pharmaceuticals INC engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, and dietary supplements.

Recent news